{"abstract":"This notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), announces that the Department of Health and Human Services is contemplating the grant of an exclusive license to practice the inventions embodied in U.S. Provisional Patent Application Serial No. 60/611,789, entitled \"Method of Detecting Cancer Based On Immune Reaction To BORIS\" filed September 21, 2004 (E-241-2004/0-US-01); U.S. Provisional Patent Application Serial No. 60/358,889, entitled \"Brother of The Regulator of Imprinted Sites (BORIS)\" filed February 22, 2001 (E-227-2001/0-US-01); PCT Application No. PCT/US03/05186, entitled \"Brother of The Regulator of Imprinted Sites (BORIS)\" filed February 21, 2003 (E-227-2001/0-PCT-02); and U.S. Patent Application Serial No. 10/505,377, entitled \"Brother of The Regulator of Imprinted Sites (BORIS)\" filed August 19, 2004 (E-227-2001/-0-US-03), to NewLink Genetics Corporation, having a place of business in Ames, Iowa. The prospective exclusive territory may be United States, Canada, Europe and Japan, and the field of use may be limited to manufacture and sale of Analyte Specific Reagents or FDA-approved in vitro diagnostics for cancer and cancer predisposition.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2005/05/05/05-8967.html","cfr_references":[],"citation":"70 FR 23883","comment_url":null,"comments_close_on":"2005-07-05","correction_of":null,"corrections":[],"dates":"Only written comments and/or license applications which are received by the National Institutes of Health on or before July 5, 2005 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"05-8967","effective_on":null,"end_page":23884,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2005/05/05/05-8967.xml","html_url":"https://www.federalregister.gov/documents/2005/05/05/05-8967/prospective-grant-of-an-exclusive-license-cancer-diagnostic-based-on-detecting-expression-of-human","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/05-8967?publication_date=2005-05-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2005-05-05/05-8967/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":13,"last_updated":"2026-04-04 14:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2005-05-05/pdf/05-8967.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2005-05-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2005/05/05/05-8967.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2011-11-12T16:00:44Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":23883,"subtype":null,"title":"Prospective Grant of an Exclusive License: Cancer Diagnostic Based on Detecting Expression of Human Brother of Regulator of Imprinted Sites (“BORIS”) and BORIS Antibodies","toc_doc":"NewLink Genetics Corp.","toc_subject":"Patent licenses; non-exclusive, exclusive, or partially exclusive:","topics":[],"type":"Notice","volume":70}